Supplemental
oxygen is a life-saving intervention administered to individuals suffering from respiratory distress, including adults with
acute lung injury (ALI) and
acute respiratory distress syndrome (ARDS). Despite the clinical benefit, supplemental
oxygen can create a hyperoxic environment that increases
reactive oxygen species, oxidative stress, and
lung injury. We have previously shown that
cytochrome P450 (CYP)1A
enzymes decrease susceptibility to
hyperoxia-induced
lung injury. In this investigation, we determined the role of CYP1B1 in hyperoxic
lung injury in vivo. Eight- to ten-week old C57BL/6 wild type (WT) and Cyp1b1-/- mice were exposed to
hyperoxia (>95% O2) for 24-72 h or maintained in room air (21% O2).
Lung injury was assessed by histology and lung weight to
body weight (LW/BW) ratios. Extent of
inflammation was determined by assessing pulmonary neutrophil infiltration and
cytokine levels. Lipid peroxidation markers were quantified by gas chromatography mass spectrometry, and oxidative
DNA adducts were quantified by 32P-postlabeling as markers of oxidative stress. We found that Cyp1b1-/- mice displayed attenuation of lung weight and
pulmonary edema, particularly after 48-72 h of
hyperoxia compared with WT controls. Further, Cyp1b1-/- mice displayed decreased levels of pulmonary oxidative
DNA adducts and pulmonary isofurans after 24 h of
hyperoxia. Cyp1b1-/- mice also showed increased pulmonary
CYP1A1 and 1A2 and
mRNA expression. In summary, our results support the hypothesis that Cyp1b1-/- mice display decreased hyperoxic
lung injury than wild type counterparts and that CYP1B1 may act as a
pro-oxidant during
hyperoxia exposure, contributing to increases in oxidative DNA damage and accumulation of
lipid hydroperoxides.